Cargando…
Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer
SIMPLE SUMMARY: Nowadays, in clinics, there is a lack of reliable biomarkers that could serve as tools allowing for early cancer detection, prediction of therapy response, tumor recurrence, and TNBC course. In this review, we summarized the most recent findings on the applicability of unique blood c...
Autores principales: | Powrózek, Tomasz, Ochieng Otieno, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833777/ https://www.ncbi.nlm.nih.gov/pubmed/35159070 http://dx.doi.org/10.3390/cancers14030803 |
Ejemplares similares
-
The Landscape of Small Non-Coding RNAs in Triple-Negative Breast Cancer
por: Guo, Yan, et al.
Publicado: (2018) -
Systematic characterization of non‐coding RNAs in triple‐negative breast cancer
por: Mei, Jie, et al.
Publicado: (2020) -
Non-Coding RNAs Associated With Radioresistance in Triple-Negative Breast Cancer
por: Aranza-Martínez, Alberto, et al.
Publicado: (2021) -
Recent Clinical Advances on Long Non-Coding RNAs in Triple-Negative Breast Cancer
por: Singh, Desh Deepak, et al.
Publicado: (2023) -
Identification of novel long non-coding RNAs in triple-negative breast cancer
por: Shen, Xiaokun, et al.
Publicado: (2015)